13F filer · CIK 1990717
TRV GP V, LLC
Boston, MA · filing since Q4 2024 · last filing Aug 10, 2026
Reported value
$498.2M
+$97.2M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $35.6M
Top-10 weight
100.0%
Biggest buys vs Q1 2026
No new or increased positions this quarter.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | RAPPORT THERAPEUTICS, INC. | -854,708 | -12.0% | $-35.6M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | RAPPORT THERAPEUTICS, INC.COM | 6,280,525 | $261.7M | 52.53% |
| 2 | SEPTERNA, INC.COM | 6,215,591 | $208.2M | 41.78% |
| 3 | MAZE THERAPEUTICS, INC.COM | 950,800 | $28.4M | 5.69% |